Methods for development of the european commission initiative on breast cancer guidelines

Holger J. Schünemann, Donata Lerda, Nadya Dimitrova, Pablo Alonso-Coello, Axel Gräwingholt, Cecily Quinn, Markus Follmann, Robert Mansel, Francesco Sardanelli, Paolo Giorgi Rossi, Annette Lebeau, Lennarth Nyström, Mireille Broeders, Lydia Ioannidou-Mouzaka, Stephen W. Duffy, Bettina Borisch, Patricia Fitzpatrick, Solveig Hofvind, Xavier Castells, Livia GiordanoSue Warman, Zuleika Saz-Parkinson

Research output: Contribution to journalArticle

Abstract

Neither breast cancer prevention and early-detection programs, nor their outcomes, are uniform across Europe. This article describes the rationale, methods, and process for development of the European Commission (EC) Initiative on Breast Cancer Screening and Diagnosis Guidelines. To be consistent with standards set by the Institute of Medicine and others, the EC followed 6 general principles. First, the EC selected, via an open call, a panel with broad representation of areas of expertise. Second, it ensured that all recommendations were supported by systematic reviews. Third, the EC separately considered important subgroups of women, included patient advocates in the guidelines development group, and focused on good communication to inform women's decisions. Fourth, EC rules on conflicts of interest were followed and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests. Fifth, it focused its recommendations on outcomes that matter to women, and certainty of the evidence is rated for each. Sixth, the EC elicited stakeholder feedback to ensure that the recommendations remain up to date and relevant to practice. This article describes the approach and highlights ways of disseminating and adapting the recommendations both within and outside Europe, using innovative information technology tools.

Original languageEnglish
Pages (from-to)273-280
Number of pages8
JournalAnnals of Internal Medicine
Volume171
Issue number4
DOIs
Publication statusPublished - Aug 20 2019

Fingerprint

Guidelines
Breast Neoplasms
Conflict of Interest
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Early Detection of Cancer
Communication
Technology

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Schünemann, H. J., Lerda, D., Dimitrova, N., Alonso-Coello, P., Gräwingholt, A., Quinn, C., ... Saz-Parkinson, Z. (2019). Methods for development of the european commission initiative on breast cancer guidelines. Annals of Internal Medicine, 171(4), 273-280. https://doi.org/10.7326/M18-3445

Methods for development of the european commission initiative on breast cancer guidelines. / Schünemann, Holger J.; Lerda, Donata; Dimitrova, Nadya; Alonso-Coello, Pablo; Gräwingholt, Axel; Quinn, Cecily; Follmann, Markus; Mansel, Robert; Sardanelli, Francesco; Rossi, Paolo Giorgi; Lebeau, Annette; Nyström, Lennarth; Broeders, Mireille; Ioannidou-Mouzaka, Lydia; Duffy, Stephen W.; Borisch, Bettina; Fitzpatrick, Patricia; Hofvind, Solveig; Castells, Xavier; Giordano, Livia; Warman, Sue; Saz-Parkinson, Zuleika.

In: Annals of Internal Medicine, Vol. 171, No. 4, 20.08.2019, p. 273-280.

Research output: Contribution to journalArticle

Schünemann, HJ, Lerda, D, Dimitrova, N, Alonso-Coello, P, Gräwingholt, A, Quinn, C, Follmann, M, Mansel, R, Sardanelli, F, Rossi, PG, Lebeau, A, Nyström, L, Broeders, M, Ioannidou-Mouzaka, L, Duffy, SW, Borisch, B, Fitzpatrick, P, Hofvind, S, Castells, X, Giordano, L, Warman, S & Saz-Parkinson, Z 2019, 'Methods for development of the european commission initiative on breast cancer guidelines', Annals of Internal Medicine, vol. 171, no. 4, pp. 273-280. https://doi.org/10.7326/M18-3445
Schünemann HJ, Lerda D, Dimitrova N, Alonso-Coello P, Gräwingholt A, Quinn C et al. Methods for development of the european commission initiative on breast cancer guidelines. Annals of Internal Medicine. 2019 Aug 20;171(4):273-280. https://doi.org/10.7326/M18-3445
Schünemann, Holger J. ; Lerda, Donata ; Dimitrova, Nadya ; Alonso-Coello, Pablo ; Gräwingholt, Axel ; Quinn, Cecily ; Follmann, Markus ; Mansel, Robert ; Sardanelli, Francesco ; Rossi, Paolo Giorgi ; Lebeau, Annette ; Nyström, Lennarth ; Broeders, Mireille ; Ioannidou-Mouzaka, Lydia ; Duffy, Stephen W. ; Borisch, Bettina ; Fitzpatrick, Patricia ; Hofvind, Solveig ; Castells, Xavier ; Giordano, Livia ; Warman, Sue ; Saz-Parkinson, Zuleika. / Methods for development of the european commission initiative on breast cancer guidelines. In: Annals of Internal Medicine. 2019 ; Vol. 171, No. 4. pp. 273-280.
@article{7009430929fa415684838b3412e59ebe,
title = "Methods for development of the european commission initiative on breast cancer guidelines",
abstract = "Neither breast cancer prevention and early-detection programs, nor their outcomes, are uniform across Europe. This article describes the rationale, methods, and process for development of the European Commission (EC) Initiative on Breast Cancer Screening and Diagnosis Guidelines. To be consistent with standards set by the Institute of Medicine and others, the EC followed 6 general principles. First, the EC selected, via an open call, a panel with broad representation of areas of expertise. Second, it ensured that all recommendations were supported by systematic reviews. Third, the EC separately considered important subgroups of women, included patient advocates in the guidelines development group, and focused on good communication to inform women's decisions. Fourth, EC rules on conflicts of interest were followed and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests. Fifth, it focused its recommendations on outcomes that matter to women, and certainty of the evidence is rated for each. Sixth, the EC elicited stakeholder feedback to ensure that the recommendations remain up to date and relevant to practice. This article describes the approach and highlights ways of disseminating and adapting the recommendations both within and outside Europe, using innovative information technology tools.",
author = "Sch{\"u}nemann, {Holger J.} and Donata Lerda and Nadya Dimitrova and Pablo Alonso-Coello and Axel Gr{\"a}wingholt and Cecily Quinn and Markus Follmann and Robert Mansel and Francesco Sardanelli and Rossi, {Paolo Giorgi} and Annette Lebeau and Lennarth Nystr{\"o}m and Mireille Broeders and Lydia Ioannidou-Mouzaka and Duffy, {Stephen W.} and Bettina Borisch and Patricia Fitzpatrick and Solveig Hofvind and Xavier Castells and Livia Giordano and Sue Warman and Zuleika Saz-Parkinson",
year = "2019",
month = "8",
day = "20",
doi = "10.7326/M18-3445",
language = "English",
volume = "171",
pages = "273--280",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "4",

}

TY - JOUR

T1 - Methods for development of the european commission initiative on breast cancer guidelines

AU - Schünemann, Holger J.

AU - Lerda, Donata

AU - Dimitrova, Nadya

AU - Alonso-Coello, Pablo

AU - Gräwingholt, Axel

AU - Quinn, Cecily

AU - Follmann, Markus

AU - Mansel, Robert

AU - Sardanelli, Francesco

AU - Rossi, Paolo Giorgi

AU - Lebeau, Annette

AU - Nyström, Lennarth

AU - Broeders, Mireille

AU - Ioannidou-Mouzaka, Lydia

AU - Duffy, Stephen W.

AU - Borisch, Bettina

AU - Fitzpatrick, Patricia

AU - Hofvind, Solveig

AU - Castells, Xavier

AU - Giordano, Livia

AU - Warman, Sue

AU - Saz-Parkinson, Zuleika

PY - 2019/8/20

Y1 - 2019/8/20

N2 - Neither breast cancer prevention and early-detection programs, nor their outcomes, are uniform across Europe. This article describes the rationale, methods, and process for development of the European Commission (EC) Initiative on Breast Cancer Screening and Diagnosis Guidelines. To be consistent with standards set by the Institute of Medicine and others, the EC followed 6 general principles. First, the EC selected, via an open call, a panel with broad representation of areas of expertise. Second, it ensured that all recommendations were supported by systematic reviews. Third, the EC separately considered important subgroups of women, included patient advocates in the guidelines development group, and focused on good communication to inform women's decisions. Fourth, EC rules on conflicts of interest were followed and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests. Fifth, it focused its recommendations on outcomes that matter to women, and certainty of the evidence is rated for each. Sixth, the EC elicited stakeholder feedback to ensure that the recommendations remain up to date and relevant to practice. This article describes the approach and highlights ways of disseminating and adapting the recommendations both within and outside Europe, using innovative information technology tools.

AB - Neither breast cancer prevention and early-detection programs, nor their outcomes, are uniform across Europe. This article describes the rationale, methods, and process for development of the European Commission (EC) Initiative on Breast Cancer Screening and Diagnosis Guidelines. To be consistent with standards set by the Institute of Medicine and others, the EC followed 6 general principles. First, the EC selected, via an open call, a panel with broad representation of areas of expertise. Second, it ensured that all recommendations were supported by systematic reviews. Third, the EC separately considered important subgroups of women, included patient advocates in the guidelines development group, and focused on good communication to inform women's decisions. Fourth, EC rules on conflicts of interest were followed and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests. Fifth, it focused its recommendations on outcomes that matter to women, and certainty of the evidence is rated for each. Sixth, the EC elicited stakeholder feedback to ensure that the recommendations remain up to date and relevant to practice. This article describes the approach and highlights ways of disseminating and adapting the recommendations both within and outside Europe, using innovative information technology tools.

UR - http://www.scopus.com/inward/record.url?scp=85071942143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071942143&partnerID=8YFLogxK

U2 - 10.7326/M18-3445

DO - 10.7326/M18-3445

M3 - Article

C2 - 31330534

AN - SCOPUS:85071942143

VL - 171

SP - 273

EP - 280

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 4

ER -